Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, reports selling shares on March 4th and 5th, 2025.

Summary

• Saba Capital Management, L.P., a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), filed a Form 4 indicating changes in beneficial ownership.
• On March 4, 2025, Saba Capital Management sold 51,096 shares of common stock at a price of $15.36 per share.
• Following this transaction, the number of shares indirectly beneficially owned was 12,262,479.
• On March 5, 2025, Saba Capital Management sold 97,976 shares of common stock at a price of $15.36 per share.
• Following this transaction, the number of shares indirectly beneficially owned was 12,164,503.
• Boaz Weinstein, also listed as a 10% owner and director, is associated with these transactions.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the reduction in Saba Capital's stake, which could indicate a lack of confidence or a shift in investment strategy. However, the magnitude of the sale is relatively small compared to their overall holdings.

Negatives

• Saba Capital Management reduced its holdings in BlackRock Capital Allocation Term Trust.

Risks

• Continued selling pressure from large shareholders like Saba Capital could negatively impact the stock price.

Industry Context

Hedge funds like Saba Capital Management often adjust their positions in closed-end funds like BCAT to manage portfolio risk and capital allocation.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital's reduced stake, potentially leading to price volatility.

Key Dates